The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec’s multiple sclerosis drug Tysabri. Tysabri is one of a handful of drugs used to control multiple sclerosis, a debilitating disease in which the body attacks its own nervous system. Prescribing of the drug has been tightly controlled by the FDA because of a rare infection that causes inflammation of the brain.
Article source found here
..
..Comments for each blog posting are always appreciated. Article source found here
..
Please use the link found below, to leave comments.. ..
All comments are moderated to reduce SPAM and bad language
All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
- Click to: REGISTER - For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"
Help us to educate $ DONATE NOW PLEASE $
"MS Views and News" is a 501©(3) Not-For-Profit organization
as recognized by the Internal Revenue Service
All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer: 'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................
0 comments:
Post a Comment